Letter by Groothof et al Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial".

Groothof, Dion; Post, Adrian; Bakker, Stephan J L

Groothof, Dion; Post, Adrian; Bakker, Stephan J L.

Afiliação

Groothof D; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, the Netherlands.
Post A; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, the Netherlands.
Bakker SJL; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, the Netherlands.

Circulation ; 146(2): e5-e6, 2022 07 12.

Article em En | MEDLINE | ID: mdl-35858158

Assuntos

Diabetes Mellitus Tipo 2; Hipoglicemiantes; Ensaios Clínicos como Assunto; Diabetes Mellitus Tipo 2/tratamento farmacológico; Humanos; Hipoglicemiantes/uso terapêutico; Prolina/uso terapêutico; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemiantes Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google